Researchers investigate the underlying mechanisms of endothelial insulin resistance involved in obesity-associated diabetes.

A groundbreaking study has pinpointed the hormone that plays a role in type 2 diabetes among overweight individuals, paving the way for new preventive strategies.

Adrenomedullin (ADM) inhibits endothelial insulin signaling, contributing to obesity-associated insulin resistance, according ...

Adrenomedullin, a hormone first identified in an adrenal medullary tumor, disrupts the effect of insulin on the endothelium of blood vessels, leading to insulin resistance linked to obesity and type 2 ...

The hormone adrenomedullin disrupts insulin signaling in blood vessel cells, contributing to systemic insulin resistance in obesity-associated type 2 diabetes, according to a new study. Blocking ...

But what is the cause of the development of insulin resistance on the endothelium? Further experiments led the researchers to adrenomedullin. This hormone is released from fat cells into the blood in ...

Logroño. Spain, Feb 7 (EFE).— Researchers have identified the molecular mechanism by which the peptide hormone, adrenomedullin, triggers type 2 diabetes in obese persons, paving the way for new ...